{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:32:44Z","timestamp":1744716764051,"version":"3.37.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1097\/ftd.0b013e31815b3e13","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T02:16:39Z","timestamp":1236219399000},"page":"807-814","source":"Crossref","is-referenced-by-count":15,"title":["Orogastric and Intravenous Indomethacin Administration to Very Premature Neonates With Patent Ductus Arteriosus: Population Pharmacokinetics, Absolute Bioavailability, and Treatment Outcome"],"prefix":"10.1097","volume":"29","author":[{"given":"Mohammed Al","family":"Za'abi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Tudehope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Woodgate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-an","family":"Collie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Charles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-14-20210129","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/adc.65.1_Spec_No.24","article-title":"Postnatal circulatory adaptation in healthy term and preterm neonates.","volume":"65","author":"Evans","year":"1990","journal-title":"Arch Dis Child"},{"key":"R2-14-20210129","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1542\/neo.4-8-e215","article-title":"Pharmacologic closure of patent ductus arteriosus in the neonate.","volume":"4","author":"Narayanan","year":"2003","journal-title":"NeoReviews"},{"key":"R4-14-20210129","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0022-3476(83)80022-5","article-title":"A. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.","volume":"102","author":"Gersony","year":"1983","journal-title":"J Pediatr"},{"key":"R5-14-20210129","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/adc.58.4.267","article-title":"Indomethacin treatment for patent ductus arteriosus in very low birthweight infants: double blind trial.","volume":"58","author":"Rudd","year":"1983","journal-title":"Arch Dis Child"},{"key":"R6-14-20210129","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00441143","article-title":"Variability of serum indomethacin concentrations after oral and intravenous administration to preterm infants.","volume":"138","author":"Mrongovius","year":"1982","journal-title":"Eur J Pediatr"},{"key":"R7-14-20210129","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0022-3476(80)80445-8","article-title":"Pharmacokinetics of intravenously administered indomethacin in premature infants.","volume":"97","author":"Thalji","year":"1980","journal-title":"J Pediatr"},{"key":"R8-14-20210129","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0022-3476(80)80446-X","article-title":"The disposition of indomethacin in preterm babies.","volume":"97","author":"Yaffe","year":"1980","journal-title":"J Pediatr"},{"key":"R9-14-20210129","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1056\/NEJM198107093050203","article-title":"Pharmacokinetics of indomethacin in the neonate. Relation of plasma indomethacin levels to response of the ductus arteriosus.","volume":"305","author":"Brash","year":"1981","journal-title":"N Engl J Med"},{"key":"R10-14-20210129","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/clpt.1991.65","article-title":"Population pharmacokinetics of intravenous indomethacin in neonates with symptomatic patent ductus arteriosus.","volume":"49","author":"Wiest","year":"1991","journal-title":"Clin Pharmacol Ther"},{"key":"R11-14-20210129","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2125.2004.02139.x","article-title":"Intravenous indomethacin in preterm infants with symptomatic patent ductus arteriosus. A population pharmacokinetic study.","volume":"58","author":"Smyth","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"R12-14-20210129","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0022-3476(96)80123-5","article-title":"Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies.","volume":"128","author":"Clyman","year":"1996","journal-title":"J Pediatr"},{"key":"R13-14-20210129","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1651-2227.1983.tb09693.x","article-title":"Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome.","volume":"72","author":"Kaapa","year":"1983","journal-title":"Acta Paediatr Scand"},{"key":"R14-14-20210129","first-page":"20","article-title":"Indomethacin for patent ductus arteriosus closure. Application of serum concentrations and pharmacodynamics to improve response.","volume":"10","author":"Gal","year":"1990","journal-title":"J Perinatol"},{"key":"R15-14-20210129","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00003246-200202000-00013","article-title":"Effect of age and birth weight on indomethacin pharmacodynamics in neonates treated for patent ductus arteriosus.","volume":"30","author":"Shaffer","year":"2002","journal-title":"Crit Care Med"},{"key":"R16-14-20210129","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jchromb.2005.11.025","article-title":"A rapid and sensitive microscale HPLC method for the determination of indomethacin in plasma of premature neonates with patent ductus arteriosus.","volume":"830","author":"Al-Zaabi","year":"2006","journal-title":"J Chromatogr B"},{"key":"R18-14-20210129","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1177\/0091270003253624","article-title":"Model appropriateness and population pharmacokinetic modeling.","volume":"43","author":"Ette","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"R19-14-20210129","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2125.1996.tb00182.x","article-title":"Theophylline population pharmacokinetics from routine monitoring data in very premature infants with apnoea.","volume":"41","author":"Lee","year":"1996","journal-title":"Br J Clin Pharmacol"},{"key":"R20-14-20210129","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2165\/00003088-199324050-00007","article-title":"Pharmacokinetics of indomethacin in the elderly.","volume":"24","author":"Oberbauer","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"R21-14-20210129","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00003088-198106040-00001","article-title":"Clinical pharmacokinetics of indomethacin.","volume":"6","author":"Helleberg","year":"1981","journal-title":"Clin Pharmacokinet"},{"key":"R22-14-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-198900171-00004","article-title":"Clinical pharmacology of the perinatal period and early infancy.","volume":"17","author":"Morselli","year":"1989","journal-title":"Clin Pharmacokinet"},{"key":"R23-14-20210129","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000455528","article-title":"Pharmacokinetics of oral and intravenous indomethacin in preterm infants.","volume":"1","author":"Bhat","year":"1980","journal-title":"Dev Pharmacol Ther"},{"key":"R24-14-20210129","first-page":"251","article-title":"A comparison of oral and intravenous indomethacin dispositions in the premature infant with patent ductus arteriosus.","volume":"1","author":"Evans","year":"1981","journal-title":"Pediatr Pharmacol"},{"key":"R25-14-20210129","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/02724936.1992.11747606","article-title":"Preterm infants with patent ductus arteriosus: treatment with an enteral preparation of indomethacin.","volume":"12","author":"So","year":"1992","journal-title":"Ann Trop Paediatr"},{"key":"R26-14-20210129","first-page":"181","article-title":"Indomethacin therapy of patent ductus in preterm infants controlled by plasma levels.","volume":"21","author":"Lewis","year":"1985","journal-title":"Aust Paediatr J"},{"key":"R27-14-20210129","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/cpt1975183364","article-title":"Pharmacokinetics of indomethacin.","volume":"18","author":"Alvan","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"R28-14-20210129","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1542\/peds.112.2.345","article-title":"Randomized trial of prolonged low-dose versus conventional-dose indomethacin for treating patent ductus arteriosus in very low birth weight infants.","volume":"112","author":"Lee","year":"2003","journal-title":"Pediatrics"},{"key":"R29-14-20210129","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0022-3476(99)70239-8","article-title":"Short versus prolonged indomethacin therapy for patent ductus arteriosus in preterm infants.","volume":"134","author":"Tammela","year":"1999","journal-title":"J Pediatr"},{"key":"R30-14-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-2000-10010","article-title":"Low-dose continuous indomethacin in early days of age reduce the incidence of symptomatic patent ductus arteriosus without adverse effects.","volume":"17","author":"Nakamura","year":"2000","journal-title":"Am J Perinatol"},{"key":"R31-14-20210129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/adc.66.1_Spec_No.55","article-title":"Prolonged low dose indomethacin for persistent ductus arteriosus of prematurity.","volume":"66","author":"Rennie","year":"1991","journal-title":"Arch Dis Child"},{"key":"R32-14-20210129","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF00441971","article-title":"Effects of prolonged versus acute indomethacin therapy in very low birth-weight infants with patent ductus arteriosus.","volume":"147","author":"Rhodes","year":"1988","journal-title":"Eur J Pediatr"},{"key":"R33-14-20210129","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00496793","article-title":"Introduction of plasma indomethacin level monitoring and evaluation of an effective threshold level in very low birth weight infants with symptomatic patent ductus arteriosus.","volume":"141","author":"Seyberth","year":"1983","journal-title":"Eur J Pediatr"},{"key":"R34-14-20210129","first-page":"294","article-title":"Response of the patent ductus arteriosus to indomethacin treatment.","volume":"141","author":"Ramsay","year":"1987","journal-title":"Am J Dis Child"},{"key":"R35-14-20210129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00561483","article-title":"Effectiveness and pharmacokinetics of indomethacin in premature newborns with patent ductus arteriosus.","volume":"18","author":"Vert","year":"1980","journal-title":"Eur J Clin Pharmacol"},{"key":"R36-14-20210129","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/adc.59.6.537","article-title":"Intravenous indomethacin for patent ductus arteriosus.","volume":"59","author":"Smith","year":"1984","journal-title":"Arch Dis Child"},{"key":"R37-14-20210129","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/hrt.41.3.304","article-title":"Failure of indomethacin to close persistent ductus arteriosus in infants weighing under 1000 grams.","volume":"41","author":"Ivey","year":"1979","journal-title":"Br Heart J"},{"key":"R38-14-20210129","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0022-3476(95)70084-6","article-title":"Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin.","volume":"127","author":"Weiss","year":"1995","journal-title":"J Pediatr"},{"key":"R39-14-20210129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0031-6997(24)01348-6","article-title":"The pharmacology of the ductus arteriosus.","volume":"50","author":"Smith","year":"1998","journal-title":"Pharmacol Rev"},{"key":"R40-14-20210129","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1203\/00006450-198711000-00018","article-title":"In vivo constriction of the ductus arteriosus by nonsteroidal antiinflammatory drugs in near-term and preterm fetal rats.","volume":"22","author":"Momma","year":"1987","journal-title":"Pediatr Res"},{"key":"R41-14-20210129","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM198808113190602","article-title":"Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus.","volume":"319","author":"Moise","year":"1988","journal-title":"N Engl J Med"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e31815b3e13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T01:05:10Z","timestamp":1738976710000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-200712000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e31815b3e13","relation":{},"ISSN":["0163-4356"],"issn-type":[{"type":"print","value":"0163-4356"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}